Pregabalin in the treatment of depression
Key points
- Although studies have demonstrated the efficacy of the new anti-epileptic on the block, Pregabalin, in the treatment of Generalized Anxiety Disorder and Social Anxiety Disorder, there is no study so far of such efficacy for the treatment of depression.
- This case study in a patient with chronic major depression demonstrates that Pregabalin could be an effective augmenting agent to other anti-depressants, e.g.
- This added property of Pregabalin may be related to its probable GABA-ergic mechanism of action that could be soon the emerging treatment pathway for achieving better remission in chronic depression that is yet clinically problematic.
Although studies have demonstrated the efficacy of the new anti-epileptic on the block, Pregabalin, in the treatment of Generalized Anxiety Disorder and Social Anxiety Disorder, there is no study so far of such efficacy for the treatment of depression.
This case study in a patient with chronic major depression demonstrates that Pregabalin could be an effective augmenting agent to other anti-depressants, e.g. SSRI's and SNRI's.
This added property of Pregabalin may be related to its probable GABA-ergic mechanism of action that could be soon the emerging treatment pathway for achieving better remission in chronic depression that is yet clinically problematic.
Key Words: Pregabalin • depression • augmentation • anxiety • GABA
Mostafa Showraki
Community Psychiatrists Association of Toronto, Ontario, Canada, [email protected]
Journal of Psychopharmacology, Vol. 21, No. 8, 883-884 (2007)
DOI: 10.1177/0269881107078496
British Association for Psychopharmacology
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsNew Treatment Approach May be Needed for Management of Depression in Some People with Bipolar Disord
In a study published in The American Journal of Psychiatry, a team of researchers led by Mayo Clinic psychiatrist Mark Frye, M.D., attempted to identify what factors make some people with bipolar depression more likely…
13 February 2009
NewsTherapy Approved by FDA for Treatment-resistant Depression
Millions of patients with treatment-resistant clinical depression, who have struggled for years with disability and how to cope with their condition, now have an option that could help them lead more productive and…
14 October 2008
NewsSelf-guided Depression Treatment
Self-guided treatment for depression could soon be only a mouse click away. Scientists with the National Space Biomedical Research Institute (NSBRI) are developing an interactive, multi-media program that will assist…
